Financial Performance - The company's operating revenue for Q1 2022 was ¥198,484,253.44, a decrease of 21.05% compared to ¥251,417,861.93 in the same period last year[6] - Net profit attributable to shareholders was ¥2,927,401.67, down 83.13% from ¥17,353,316.50 year-on-year[6] - Basic and diluted earnings per share were both ¥0.03, down 82.35% from ¥0.17 in the same period last year[6] - The total operating revenue for the first quarter of 2022 was CNY 198,484,253.44, a decrease of 21.03% compared to CNY 251,417,861.93 in the same period last year[39] - The total profit for the current period is 2,868,868.95, down from 18,733,665.18 in the previous period[43] - The operating profit for the current period is 2,770,505.84, compared to 18,421,264.88 in the previous period[43] - The total comprehensive income attributable to the parent company is 2,992,519.77, down from 17,458,588.22 in the previous period[46] Cash Flow and Liquidity - The net cash flow from operating activities was -¥94,602,550.02, representing a significant decline of 1,240.41% compared to -¥7,057,741.90 in the previous year[6] - The company's cash and cash equivalents increased to CNY 214,855,809.10 at the end of the first quarter, up from CNY 165,888,587.05 at the beginning of the year, representing a growth of 29.5%[30] - Cash and cash equivalents at the end of the period amount to 177,784,912.37, compared to 118,169,449.15 at the end of the previous period[53] - The cash flow from operating activities shows a net outflow of -94,602,550.02, compared to -7,057,741.90 in the previous period[50] - The cash inflow from financing activities is 180,327,221.00, compared to 81,600,000.00 in the previous period[50] - The company received cash from investment activities amounting to 125,337,209.20, compared to 70,359,414.86 in the previous period[50] Assets and Liabilities - Total assets at the end of the reporting period were ¥2,022,071,032.47, an increase of 0.82% from ¥2,005,709,140.99 at the end of the previous year[6] - The total liabilities increased to CNY 1,166,678,128.98 from CNY 1,160,613,259.83, a slight rise of 0.7%[36] - Short-term borrowings rose to CNY 646,500,996.89 from CNY 483,065,938.81, marking an increase of 33.9%[36] Shareholder Information - The company reported a total of 31,590,000 shares held by Suzhou Yuanxie Sheng Enterprise Management Consulting Co., accounting for 28.58% of total shares[18] - The top 10 shareholders collectively hold 49,132,200 shares, all of which are unrestricted shares[22] - The total number of shares held by the top 10 unrestricted shareholders is 49,132,200, with no new restricted shares added during the reporting period[22] - The company has a stock incentive plan that involves granting 300,000 restricted shares, representing 0.272% of the total share capital[26] - The stock incentive plan was approved by the board on December 5, 2021, and the grant price is set at 29.81 RMB per share[26] - The stock incentive plan's first grant was completed on February 17, 2022, with 251,500 shares registered, accounting for 0.228% of the total share capital[27] Research and Development - Research and development expenses increased by 36.58% to ¥16,052,626.05 from ¥11,753,494.06 year-on-year, indicating a focus on innovation[14] Tax and Refunds - The company experienced a 58.21% decrease in tax refunds received, amounting to ¥2,231,775.40 compared to ¥5,340,596.41 in the same period last year[15] Financing Activities - The company’s cash flow from financing activities increased significantly, with cash received from borrowings rising by 111.80% to ¥172,830,000.00 from ¥81,600,000.00 year-on-year[15] - The company is actively pursuing asset acquisition and fundraising activities, as indicated by the announcements made in February and March 2022[29] Other Information - The actual controllers of the company changed after the expiration of the concerted action agreement on January 8, 2022, with Dai Jun remaining as the actual controller[23] - The company has no shareholders participating in margin trading as of the latest report[21] - The company has not disclosed any other shareholder relationships or agreements beyond the known concerted action agreement[21]
罗博特科(300757) - 2022 Q1 - 季度财报